Our thorough diligence process leverages the intellectual resources, talents and insight of professionals across our limited partner base to evaluate investment opportunities. In addition to financial return, opportunities are evaluated for potential clinical, operational and financial benefits to our limited partner health systems.

• Industry
  Healthcare segments including medical devices, medical and information technology and services. AHV has also selectively invested in other healthcare venture funds.
• Investment Size
  Approximately $5 million per round; up to $10 million per company.
• Company Stage
  Expansion- to late-stage within three to five years of a potential liquidating event.
• Adoption Potential
  Sustainable competitive advantage with compelling benefit sufficient to influence market adoption.
• Management Team
  Established team with demonstrated relevant experience, depth and capability to build the business to scale and attract customers.
• Other
  AHV typically requests a Board seat or Board observation rights for each portfolio company.